000 | 01802 a2200529 4500 | ||
---|---|---|---|
005 | 20250517190440.0 | ||
264 | 0 | _c20190802 | |
008 | 201908s 0 0 eng d | ||
022 | _a1549-4713 | ||
024 | 7 |
_a10.1016/j.ophtha.2017.10.034 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPrice, Marianne O | |
245 | 0 | 0 |
_aProspective Randomized Trial of Corneal Cross-linking Riboflavin Dosing Frequencies for Treatment of Keratoconus and Corneal Ectasia. _h[electronic resource] |
260 |
_bOphthalmology _c04 2018 |
||
300 |
_a505-511 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCollagen _xmetabolism |
650 | 0 | 4 | _aCorneal Pachymetry |
650 | 0 | 4 |
_aCorneal Stroma _xmetabolism |
650 | 0 | 4 | _aCorneal Topography |
650 | 0 | 4 | _aCross-Linking Reagents |
650 | 0 | 4 |
_aDilatation, Pathologic _xdrug therapy |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKeratoconus _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPhotochemotherapy _xmethods |
650 | 0 | 4 |
_aPhotosensitizing Agents _xadministration & dosage |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRefraction, Ocular _xphysiology |
650 | 0 | 4 |
_aRiboflavin _xadministration & dosage |
650 | 0 | 4 | _aTherapeutic Equivalency |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aUltraviolet Rays |
650 | 0 | 4 |
_aVisual Acuity _xphysiology |
700 | 1 | _aFairchild, Kelly | |
700 | 1 | _aFeng, Matthew T | |
700 | 1 | _aPrice, Francis W | |
773 | 0 |
_tOphthalmology _gvol. 125 _gno. 4 _gp. 505-511 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ophtha.2017.10.034 _zAvailable from publisher's website |
999 |
_c27852261 _d27852261 |